Cargando…

Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis

Disturbance of the gut microbiota is common in liver cirrhosis (LC) patients, the underlying mechanisms of which are yet to be unfolded. This study aims to explore the relationship between small bowel transit (SBT) and gut microbiota in LC patients. Cross-sectional design was applied with 36 LC pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yang, Jin, Ye, Li, Jun, Zhao, Lei, Li, Zhengtian, Xu, Jun, Zhao, Fuya, Feng, Jing, Chen, Huinan, Fang, Chengyuan, Shilpakar, Rojina, Wei, Yunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946013/
https://www.ncbi.nlm.nih.gov/pubmed/29780327
http://dx.doi.org/10.3389/fphys.2018.00470
_version_ 1783322105487556608
author Liu, Yang
Jin, Ye
Li, Jun
Zhao, Lei
Li, Zhengtian
Xu, Jun
Zhao, Fuya
Feng, Jing
Chen, Huinan
Fang, Chengyuan
Shilpakar, Rojina
Wei, Yunwei
author_facet Liu, Yang
Jin, Ye
Li, Jun
Zhao, Lei
Li, Zhengtian
Xu, Jun
Zhao, Fuya
Feng, Jing
Chen, Huinan
Fang, Chengyuan
Shilpakar, Rojina
Wei, Yunwei
author_sort Liu, Yang
collection PubMed
description Disturbance of the gut microbiota is common in liver cirrhosis (LC) patients, the underlying mechanisms of which are yet to be unfolded. This study aims to explore the relationship between small bowel transit (SBT) and gut microbiota in LC patients. Cross-sectional design was applied with 36 LC patients and 20 healthy controls (HCs). The gut microbiota was characterized by 16S rRNA gene sequencing. The Firmicutes/Bacteroidetes (F/B) ratio and the Microbial Dysbiosis index (MDI) were used to evaluate the severity of microbiota dysbiosis. The scintigraphy method was performed in patients to describe the objective values of SBT. Patients were then subdivided according to the Child–Pugh score (threshold = 5) or SBT value (threshold = 0.6) for microbiota analysis. LC patients were characterized by an altered gut microbiota; F/B ratios and MDI were higher than HC in both Child_5 (14.00 ± 14.69 vs. 2.86 ± 0.99, p < 0.01; 0.49 ± 0.80 vs. -0.47 ± 0.69, p < 0.01) and Child_5+ (15.81 ± 15.11 vs. 2.86±0.99, p < 0.01; 1.11 ± 1.05 vs. -0.47 ± 0.69, p < 0.01) sub-groups in patients. Difference in the gut microbiota between Child_ 5 and Child_5+ patients was inappreciable, but the SBT was relatively slower in Child_5+ patients (43 ± 26% vs. 80 ± 15%, p < 0.05). Compared with the Child–Pugh score indicators, SBT showed stronger associations with bacterial genera. A clear difference in the gut microbiota was observed between SBT_0.6- and SBT_0.6+ patients [Pr(>F) = 0.0068, pMANOVA], with higher F/B ratios and MDI in SBT_0.6- patients (19.71 ± 16.62 vs. 7.33 ± 6.65, p < 0.01; 1.02 ± 0.97 vs. 0.20 ± 0.58, p < 0.01). Similar results were observed between the SBT_0.6- and SBT_0.6+ sub-groups of patients with normal liver function and a Child–Pugh score of 5. SBT was negatively correlated with both the F/B ratio and MDI (r = -0.34, p < 0.05; r = -0.38, p < 0.05). Interestingly, an increased capacity for the inferred pathway “bacterial invasion of epithelial cells” in patients, was highly negatively correlated with SBT (r = -0.57, p < 0.01). The severity of microbiota dysbiosis in LC patients depends on SBT rather than Child–Pugh score. SBT per se might be significantly related to the gut microbiota abnormalities observed in patients with LC.
format Online
Article
Text
id pubmed-5946013
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-59460132018-05-18 Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis Liu, Yang Jin, Ye Li, Jun Zhao, Lei Li, Zhengtian Xu, Jun Zhao, Fuya Feng, Jing Chen, Huinan Fang, Chengyuan Shilpakar, Rojina Wei, Yunwei Front Physiol Physiology Disturbance of the gut microbiota is common in liver cirrhosis (LC) patients, the underlying mechanisms of which are yet to be unfolded. This study aims to explore the relationship between small bowel transit (SBT) and gut microbiota in LC patients. Cross-sectional design was applied with 36 LC patients and 20 healthy controls (HCs). The gut microbiota was characterized by 16S rRNA gene sequencing. The Firmicutes/Bacteroidetes (F/B) ratio and the Microbial Dysbiosis index (MDI) were used to evaluate the severity of microbiota dysbiosis. The scintigraphy method was performed in patients to describe the objective values of SBT. Patients were then subdivided according to the Child–Pugh score (threshold = 5) or SBT value (threshold = 0.6) for microbiota analysis. LC patients were characterized by an altered gut microbiota; F/B ratios and MDI were higher than HC in both Child_5 (14.00 ± 14.69 vs. 2.86 ± 0.99, p < 0.01; 0.49 ± 0.80 vs. -0.47 ± 0.69, p < 0.01) and Child_5+ (15.81 ± 15.11 vs. 2.86±0.99, p < 0.01; 1.11 ± 1.05 vs. -0.47 ± 0.69, p < 0.01) sub-groups in patients. Difference in the gut microbiota between Child_ 5 and Child_5+ patients was inappreciable, but the SBT was relatively slower in Child_5+ patients (43 ± 26% vs. 80 ± 15%, p < 0.05). Compared with the Child–Pugh score indicators, SBT showed stronger associations with bacterial genera. A clear difference in the gut microbiota was observed between SBT_0.6- and SBT_0.6+ patients [Pr(>F) = 0.0068, pMANOVA], with higher F/B ratios and MDI in SBT_0.6- patients (19.71 ± 16.62 vs. 7.33 ± 6.65, p < 0.01; 1.02 ± 0.97 vs. 0.20 ± 0.58, p < 0.01). Similar results were observed between the SBT_0.6- and SBT_0.6+ sub-groups of patients with normal liver function and a Child–Pugh score of 5. SBT was negatively correlated with both the F/B ratio and MDI (r = -0.34, p < 0.05; r = -0.38, p < 0.05). Interestingly, an increased capacity for the inferred pathway “bacterial invasion of epithelial cells” in patients, was highly negatively correlated with SBT (r = -0.57, p < 0.01). The severity of microbiota dysbiosis in LC patients depends on SBT rather than Child–Pugh score. SBT per se might be significantly related to the gut microbiota abnormalities observed in patients with LC. Frontiers Media S.A. 2018-05-01 /pmc/articles/PMC5946013/ /pubmed/29780327 http://dx.doi.org/10.3389/fphys.2018.00470 Text en Copyright © 2018 Liu, Jin, Li, Zhao, Li, Xu, Zhao, Feng, Chen, Fang, Shilpakar and Wei. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Liu, Yang
Jin, Ye
Li, Jun
Zhao, Lei
Li, Zhengtian
Xu, Jun
Zhao, Fuya
Feng, Jing
Chen, Huinan
Fang, Chengyuan
Shilpakar, Rojina
Wei, Yunwei
Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis
title Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis
title_full Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis
title_fullStr Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis
title_full_unstemmed Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis
title_short Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis
title_sort small bowel transit and altered gut microbiota in patients with liver cirrhosis
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946013/
https://www.ncbi.nlm.nih.gov/pubmed/29780327
http://dx.doi.org/10.3389/fphys.2018.00470
work_keys_str_mv AT liuyang smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis
AT jinye smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis
AT lijun smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis
AT zhaolei smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis
AT lizhengtian smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis
AT xujun smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis
AT zhaofuya smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis
AT fengjing smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis
AT chenhuinan smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis
AT fangchengyuan smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis
AT shilpakarrojina smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis
AT weiyunwei smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis